| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +45.45% | +14.10% | +0.29% | +13.81% | +2.13% | — |
| 14d | 11 | +81.82% | +13.35% | +1.55% | +11.80% | +7.66% | — |
| 30d | 11 | +100.00% | +11.19% | +2.40% | +8.79% | +3.57% | — |
| 60d | 11 | +63.64% | +5.20% | +0.29% | +1.18% | -0.55% | — |
| 90d | 11 | +54.55% | +3.46% | +4.25% | -0.79% | -7.37% | — |
| 180d | 11(4 pending) | +0.00% | -33.37% | +2.31% | -35.68% | -34.30% | — |
| 1y | 11(6 pending) | +0.00% | -52.22% | +10.44% | -62.66% | -65.45% | — |
| 2y | 11(8 pending) | +0.00% | -86.74% | +30.39% | -117.13% | -117.13% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 30,978 | $0.81 | $25.0K | 30,978 | Mar 31, 2026 | Apr 1, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 30,978 | — | — | 30,978 | Mar 31, 2026 | Apr 1, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,380 | — | — | 40,380 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,095 | — | — | 43,528 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 5,700 | $0.89 | $5.1K | 33,433 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 5,700 | — | — | 5,700 | Jan 30, 2026 | Feb 2, 2026 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 5,000 | — | — | 5,000 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 5,000 | $1.17 | $5.8K | 27,733 | Dec 10, 2025 | Dec 11, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,365 | — | — | 22,733 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,460 | — | — | 13,460 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 50 | $2.46 | $123 | 19,368 | Oct 11, 2024 | Oct 16, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 450 | $2.61 | $1.2K | 19,318 | Oct 10, 2024 | Oct 15, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,365 | — | — | 18,868 | Mar 28, 2024 | Mar 28, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,460 | — | — | 13,460 | Mar 28, 2024 | Mar 28, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 505 | — | — | 505 | Mar 13, 2024 | Mar 14, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 1,010 | $7.29 | $7.4K | 15,503 | Mar 13, 2024 | Mar 14, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASE SrVP/CFO/Prin Fin & Acct Ofcr | 505 | — | — | 505 | Mar 13, 2024 | Mar 14, 2024 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,000 | $5.25 | $5.3K | 14,493 | Feb 27, 2023 | Feb 27, 2023 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 269,879 | — | — | 269,879 | Jan 30, 2023 | Jan 30, 2023 ↗ | View → |
| APRE APREA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 539,758 | — | — | 539,758 | Jan 30, 2023 | Jan 30, 2023 ↗ | View → |